Loss of MSH2 protein expression is a risk factor in early stage cervical cancer.

MLA

Nijhuis, E. R., et al. “Loss of MSH2 Protein Expression Is a Risk Factor in Early Stage Cervical Cancer.” Journal of Clinical Pathology, vol. 60, no. 7, July 2007, pp. 824–30. EBSCOhost, https://doi.org/10.1136/jcp.2005.036038.

APA

Nijhuis, E. R., Nijman, H. W., Oien, K. A., Bell, A., ten Hoor, K. A., Reesink-Peters, N., Boezen, H. M., Hollema, H., & van der Zee, A. G. J. (2007). Loss of MSH2 protein expression is a risk factor in early stage cervical cancer. Journal of Clinical Pathology, 60(7), 824–830. https://doi.org/10.1136/jcp.2005.036038

Chicago

Nijhuis, E R, H W Nijman, K A Oien, A Bell, K A ten Hoor, N Reesink-Peters, H M Boezen, H Hollema, and A G J van der Zee. 2007. “Loss of MSH2 Protein Expression Is a Risk Factor in Early Stage Cervical Cancer.” Journal of Clinical Pathology 60 (7): 824–30. doi:10.1136/jcp.2005.036038.